FDA transparency rebuffed in report

Share this article:
A minority staff report from the House Energy & Commerce Committee says FDA deputy commissioner Janet Woodcock and her successor as director of drugs Steven Galson had the lowest reporting rates of all agency officials required to report their meetings with industry and outside entities.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.